Tag Archives: Professor Seppo Ylä-Herttuala

NIB Supports FinVector’s New Gene Therapy Facility in Kuopio to Enhance Cancer Treatment Capabilities

Posted on 10, October 2024 by

(IN BRIEF) FinVector, a leading biopharmaceutical company, has inaugurated a cutting-edge production facility in Kuopio, Finland, aimed at manufacturing gene therapy products. The new Finport facility, which is set to become one of the world’s largest for such therapies, represents … Read the full press release →

Posted in Banks, Business, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology

Tagged , , , , , , , , , ,